Brainstorm to unveil results from mid-stage NurOwn study in ALS on Monday; shares up big today - BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) | Seeking Alpha
Mayo is conducting clinical trials on the Nurown Stem Cell application. They are accepting limited enrollment. The email address is [email protected] If you contact them and give them your name, age, address and contact info you will be put on a waiting list. Worth a shot.
Vince
NEW YORK (TheStreet) -- Shares of Brainstorm Cell Therapeutics (BCLI) soared 20.88% to $4.69 on higher-than-average volume in morning trading Wednesday ahead of the biotech company's data release on Monday.
Brainstorm intends to release the final results from its Phase 2a trial of its stem...
Danged mod triggers:
------------
Haredi leader Rabbi Refoel Shmulevitz, a victim of the motor neuron disease, amyotrophic lateral sclerosis (ALS), may be the first known patient cured of ALS, which he was diagnosed with two years ago. ALS, more commonly known as Lou Gehrigs’ disease after the...
BrainStorm Cell Therapeutics - October 6, 2014
"The completion of patients follow-up in this second clinical trial of NurOwn™ is an important milestone in its clinical development,” stated Dr. Yael Gothelf, PhD, Vice President of Scientific and Regulatory Affairs for BrainStorm. “We are very...
Hello,
My mom wants to try this trial. It was just approved at Mayo Clinic. Does anyone have experience with this or have any information? It looks like the trials so far have been promising.
Lou Gehrig's disease patient: Brainstorm Cell treatment helped me
Avichai Kremer is the first patient to be treated with Brainstorm Cell's drug, NurOwn, on the basis of a special approval.
4 August 11 15:19, Yael Gruntman and Gali Weinreb
A patient with amyotrophic lateral sclerosis (ALS...
age
als
back
breathing
cell
clinical
death
diagnosed
diagnosis
fda
feeding
feeding tube
food
health
hours
improvement
lou gehrig's disease
medical
mnd
nurown
paralyzed
speech
stem cell
stem cells
tests
treatment